top of page
News
MitoSense’s MOT™ Technology Featured In Newsmax Article Highlighting Secretary Kennedy’s Vision To Tackle Mitochondria Dysfunction To Fight Chronic Disease
MitoSense’s MOT™ technology was featured in a recent Newsmax article. The article highlights how U.S. Department of Health and Human...
2 days ago
MitoSense Secures Japanese Patent for Groundbreaking Mitochondria-Based Therapy for Neurodegenerative Diseases
February 4, 2025 – Plymouth, MA – MitoSense Inc., a pioneering biotechnology company specializing in mitochondria-based therapeutics, is...
Feb 3
MitoSense, Inc. Secures U.S. Patent for Innovative Treatment of Neurodegenerative Diseases
Plymouth, MA, Dec 2, 2024 – MitoSense, Inc., a pioneering research and development company focused on treatments for neurodegenerative...
Dec 2, 2024
MitoSense Inc. Publishes Breakthrough Study on Cryopreserved Fibroblast and Mesenchymal Stem Cells as Alternative Mitochondrial Donors
Plymouth, MA – November 12, 2024 – MitoSense Inc., a leader in mitochondria lresearch and innovation, proudly announces the publication...
Nov 12, 2024
bottom of page